Chris Moriarty

Chris Moriarty is an accomplished professional with a strong background in Immunology and Biochemistry. He studied Immunology and Biochemistry at Queen's University Belfast, where he earned a B.Sc (Hons) degree. Moriarty has held key positions in various organizations, showcasing his leadership and expertise.

With extensive experience in the life sciences industry, Chris Moriarty currently serves as the CEO of Affinity Biomarker Labs. Previously, he excelled as the Business Development Manager at Fusion Antibodies Plc, Global Manager of the Pharma Services Division at Randox Laboratories, and Director at OFL Limited.